US2009137020A1PendingUtilityA1

Method of reverse transcription

Assignee: PROMEGA CORPPriority: Mar 2, 2000Filed: Jan 20, 2009Published: May 28, 2009
Est. expiryMar 2, 2020(expired)· nominal 20-yr term from priority
C12N 15/1096C12Q 1/6844C12Q 1/686C12N 9/1276C12Q 1/689C12P 19/34
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to reverse transcription of RNA, and in particular to reverse transcription by thermostable DNA polymerases. Thermoactinomyces vulgaris and Bacillus stearothermophilus possess reverse transcriptase activity in the presence of magnesium or manganese ions. Methods, compositions, and kits for reverse transcription and RT-PCR are also provided.

Claims

exact text as granted — not AI-modified
1 - 23 . (canceled) 
     
     
         24 . A kit for reverse transcription comprising:
 a) a polymerase selected from  Thermoactinomyces vulgaris  and  Bacillus stearothermophilus  polymerase,   b) purified RNA, and   c) a buffer comprising magnesium ions wherein said buffer is substantially free of manganese ions.   
     
     
         25 . The kit of  claim 24 , further comprising instructions for reverse transcription. 
     
     
         26 . The kit of  claim 24 , wherein said buffer further comprises a surfactant. 
     
     
         27 . The kit of  claim 24 , wherein said buffer has a pH of about 6 to 10. 
     
     
         28 - 29 . (canceled) 
     
     
         30 . The kit of  claim 24 , further comprising at least one additional thermostable DNA polymerase. 
     
     
         31 . A kit for reverse transcription comprising:
 a) a polymerase selected from  Thermoactinomyces vulgaris  and  Bacillus stearothermophilus  polymerase, and   b) a buffer comprising magnesium ions wherein said buffer is substantially free of manganese ions.   
     
     
         32 - 33 . (canceled) 
     
     
         34 . The kit of  claim 31 , further comprising at least one additional thermostable DNA polymerase. 
     
     
         35 . The kit of  claim 31 , further comprising instructions for reverse transcription.

Join the waitlist — get patent alerts

Track US2009137020A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.